64-31-3 → HCID 9805215, compound

HRID 1976184Notes

Reaction equation

S(O)(O)(=O)=O.[CH:6]1[C:22]2[CH2:21][C@H:20]3[N:23]([CH2:25][CH2:26][C@@:12]45[C@H:19]3[CH:18]=[CH:17][C@H:15]([OH:16])[C@@H:13]4[O:14][C:10]([C:11]=25)=[C:8]([OH:9])[CH:7]=1)[CH3:24].[O:27]=[C:28]([O-:39])[C@@H:29]([C@H:31]([C@@H:33]([C@@H:35]([CH2:37][OH:38])[OH:36])[OH:34])[OH:32])[OH:30].[Na+]>>[O:27]=[C:28]([OH:39])[C@@H:29]([C@H:31]([C@@H:33]([C@@H:35]([CH2:37][OH:38])[OH:36])[OH:34])[OH:32])[OH:30].[CH:6]1[C:22]2[CH2:21][C@H:20]3[N:23]([CH2:25][CH2:26][C@@:12]45[C@H:19]3[CH:18]=[CH:17][C@H:15]([OH:16])[C@@H:13]4[O:14][C:10]([C:11]=25)=[C:8]([OH:9])[CH:7]=1)[CH3:24]

Participants

Reactant 2

HCID 546428064-31-3

HCID 23672301Sodium Gluconate

Product 1

HCID 9805215HCID 9805215, compound

Procedure

A pharmaceutical composition prepared according to claim 20, wherein morphine sulfate and sodium gluconate are dissolved in a suitable solvent to yield morphine gluconate.

Workup

customA pharmaceutical composition prepared
dissolutionare dissolved in a suitable solvent

Sources & evidence

ORD record: ord-dca548e4d8d3481296c4d59b68d2ba02
Source dataset: uspto-grants-2001_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US06225343B1

Reaction notes

Loading…